A new draft for medical devices Stents and orthopaedic implants may come soon under stringent regulatory, proposing stricter norms for firms selling such medical devices to confirm quality.
This draft proposes a shelf life for all medical devices and also makes it mandatory for products to contain manufacturing and expiry dates. It also suggests that firms must get approval for their products from the regulator before launching them in the market. Through a gazette notification the ministry released the draft rules and the government has got comments from all stakeholders within a month after which the rules will be finalized.
The action comes in the track of increasing use of critical medical devices like stents, catheters and implants. The main feature of draft rules are mainly the need for the government regulating the medical devices sector due to the inherent risk. The rules also have exact definitions and classifications. For instance, it has categorized medical devices into 4 different classifications based on risk estimation. The ones with higher risk such as stents and implants may also require clinical trials to get approval.
In India almost $7 billion medical devices is clubbed with medicines and is regulated under the same standards. Up to now the industry has maintained the absence of a separate law and regulator poses a major challenge for the industry’s growth. Rajiv Nath of Association of Indian Medical Devices Industry, an association representing domestic manufacturers said, the latest draft regulations are an assault on `Make in India‘ program.
Multinational companies have also upraised concerns over the proposed rules saying internationally regulators allow at least ten years of shelf life and the suggested standards may push up prices of imported products as companies will have to customize packaging accordingly.
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read MoreErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read MoreTUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More